[Combining effectiveness and tolerance].
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000068180:Aripiprazole; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008134:Long-Term Care; D010349:Patient Compliance / Q000523:psychology; D010817:Physician-Patient Relations; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use; D011379:Prognosis; D011788:Quality of Life / Q000523:psychology; D015363:Quinolones / Q000009:adverse effects / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy / Q000451:nursing*; D012565:Schizophrenic Psychology; D055502:Secondary Prevention; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole